newsfilter
← Latest News
GlobeNewswire·

Vaxxinity to Host First Analyst and R&D Day in New York City on November 10, 2022

Featuring subject matter experts in neuroscience, migraine and hypercholesterolemia DALLAS, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (NASDAQ:VAXX), a U.S. company pioneering the development of a new class of